Psychotherapeutic Medications Development Program (PMDP) Workshop on NMDA Receptor Antagonists: neurotoxicity evaluation. Introduction.
Leber
P
P
Food and Drug Administration, Rockville, Maryland, USA.
D000818:Animals; D018691:Excitatory Amino Acid Antagonists / Q000633:toxicity*; D006801:Humans; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*
D018691:Excitatory Amino Acid Antagonists; D016194:Receptors, N-Methyl-D-Aspartate